Literature DB >> 3345493

Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival.

B D Minsky1, C Mies, A Recht, T A Rich, J T Chaffey.   

Abstract

In an effort to determine the patterns of failure and survival of rectosigmoid and rectal cancer, a retrospective review of 168 patients who underwent potentially curative surgery at the New England Deaconess Hospital was performed. The 5-year actuarial survival for the entire group was 67%. Survival rates decreased with increasing penetration of the bowel wall by tumor and the presence of lymph node metastasis, but only the latter reached statistical significance. Those patients who underwent an abdominoperineal resection also experienced a significant decrease in survival compared to a low anterior resection. Patterns of failure, expressed as the actuarial incidence of first failure at 5 years, were examined by stage. With the exception of stages B3 and C3, there was a trend towards increased abdominal, distant, and total failure with increasing bowel wall penetration by tumor. A similar trend was seen in local failure in those patients with positive nodes. Knowledge of these data may help identify those patients who may benefit most from adjuvant therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3345493     DOI: 10.1002/1097-0142(19880401)61:7<1408::aid-cncr2820610722>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Authors:  J Martinez-Useros; I Moreno; M J Fernandez-Aceñero; M Rodriguez-Remirez; A Borrero-Palacios; A Cebrian; T Gomez Del Pulgar; L Del Puerto-Nevado; W Li; A Puime-Otin; N Perez; M S Soengas; J Garcia-Foncillas
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

3.  Impact of anatomic location on locally recurrent rectal cancer: superior outcome for intraluminal tumour recurrence.

Authors:  Johannes Klose; Ignazio Tarantino; Thomas Schmidt; Thomas Bruckner; Yakup Kulu; Tobias Wagner; Martin Schneider; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2015-03-31       Impact factor: 3.452

Review 4.  Post-Resection Surveillance in GI Cancers.

Authors:  Neeraj Chaudhary; Vinay Kumaran; Vibha Varma; Sorabh Kapoor; Naimish Mehta; Samiran Nundy
Journal:  Indian J Surg       Date:  2013-07-11       Impact factor: 0.656

5.  Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.

Authors:  Daniel Delitto; Thomas J George; Tyler J Loftus; Peihua Qiu; George J Chang; Carmen J Allegra; William A Hall; Steven J Hughes; Sanda A Tan; Christiana M Shaw; Atif Iqbal
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

6.  T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.

Authors:  N B Merchant; J G Guillem; P B Paty; W E Enker; B D Minsky; S H Quan; D Wong; A M Cohen
Journal:  J Gastrointest Surg       Date:  1999 Nov-Dec       Impact factor: 3.452

Review 7.  Can endoscopic ultrasound predict early rectal cancers that can be resected endoscopically? A meta-analysis and systematic review.

Authors:  Srinivas R Puli; Matthew L Bechtold; Jyotsna B K Reddy; Abhishek Choudhary; Mainor R Antillon
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

Review 8.  Survival and recurrence after low anterior resection and abdominoperineal resection for rectal cancer: the results of a long-term study with a review of the literature.

Authors:  M Konn; T Morita; R Hada; Y Yamanaka; M Sasaki; H Munakata; H Suzuki; S Inoue; M Endoh; Y Sugiyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy.

Authors:  Antonio I Picon; Harvey G Moore; Stephen S Sternberg; Bruce D Minsky; Philip B Paty; David Blumberg; Stuart H Quan; W Douglas Wong; Alfred M Cohen; Jose G Guillem
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

Review 10.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.